Funnelfeedr Logo

Abarceo Pharma AB

Sverige559139-7160Active

Developing novel small molecule therapeutics targeting VDAC1 for diabetes.

Biotechnology Companyabarceo.com

Oversikt

5–9
Ansatte
2.5–5mill SEK
Omsetning
2017
Grunnlagt

Nøkkelbeslutningstakere

Mozhgan Dorkhan

Consulting CMO

Adam Bruce

CEO

Claes Post

Board Member

Claes Wollheim

CSO & Scientific Founder, Board Member

+11 flere kontakter i Funnelfeedr

Beskrivelse

Abarceo Pharma is a pre-clinical stage biotechnology company founded in 2017 as a spin-out from the Lund University Diabetes Center. It was established by world-renowned scientists specializing in diabetes research and beta-cell biology. The company has identified Voltage-Dependent Anion Channel 1 (...

Tagger

B2BHealthcarePharmaceuticalsProfessional ServicesWhite Collar

Nøkkelord

BiotechDiabetes TherapeuticsDrug DiscoveryMitochondrial DysfunctionType 2 DiabetesVDAC1 Target

Teknologier i bruk

jQuery MigratejQueryBootstrapPriority HintsWordPressVarnishApache HTTP ServerPHPMagnific PopupFitVids.JSEasy Pie ChartYouTubejQuery Mobile

Bedriftsinformasjon

Bransje
Bioteknisk forskning och utveckling
Juridisk form
Aktiebolag
MVA-nummer
SE559139716001

Beslutningstakere

15 kontakter i Funnelfeedr

Mozhgan Dorkhan

Consulting CMO

Adam Bruce

CEO

Claes Post

Board Member

Claes Wollheim

CSO & Scientific Founder, Board Member

Per Aniansson

Chairman of the Board

Ulrich Koch

Independent Board Member

William Dalby Brown

Head of Medicinal Chemistry and Screening

Henrik Otendal

CFO

Tara Heitner

Vice Chair

Albert Salehi

Scientific Founder

Jan Alenfall

COO

Andre kontakter

Steven Kahn

Scientific Advisor

Michael Karin

Scientific Advisor

Kent Bodensgaard

Scientific Advisor

Ruchi Jain

Principal Scientist

Lignende bedrifter

20 lignende bedrifter i Funnelfeedr

Utforsk mer

Spørsmål om Abarceo Pharma AB

Vil du se Funnelfeedr i aksjon?

Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.

Book en demo